Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

Nature Biotechnology

Volumn 23, Issue 3, 2005, Pages 321-328

  Wang, Zhong ^a   Zhu, Tong ^a   Qiao, Chunping ^a   Zhou, Liqiao ^a   Wang, Bing ^a   Zhang, Jian ^a   Chen, Chunlian ^a   Li, Juan ^a   Xiao, Xiao ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL CULTURE; GENES; MUSCLE; TISSUE; VECTORS;

ADENO-ASSOCIATED VIRUS SEROTYPE 8; BLOOD VESSEL BARRIER; CAPILLARY BLOOD VESSELS; VECTOR DISSEMINATION;

VIRUSES;

VIRUS VECTOR; DNA;

ADENO ASSOCIATED VIRUS; ANIMAL TISSUE; ARTICLE; CAPILLARY BLOOD; CELL DIVISION; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENE THERAPY; GENE TRANSFER; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; DRUG DELIVERY SYSTEM; EVALUATION; GENE TARGETING; GENETIC TRANSDUCTION; GENETICS; HAMSTER; HEART; HEART MUSCLE; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; METHODOLOGY; NEWBORN; VIROLOGY;

ADENO-ASSOCIATED VIRUS; ANIMALIA; CRICETINAE;

ANIMALS; ANIMALS, NEWBORN; CRICETINAE; DEPENDOVIRUS; DNA; DRUG DELIVERY SYSTEMS; GENE TARGETING; GENE THERAPY; HEART; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MUSCLE, SKELETAL; MYOCARDIUM; TRANSDUCTION, GENETIC;

EID: 19644378907     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt1073     Document Type: Article

References (49)

1. Watchko, J. et al. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum. Gene Ther. 13, 1451-1460 (2002).
2. Wang, B., Li, J. & Xiao, X. From the cover: adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. USA 97, 13714-13719 (2000).
3. van Deutekom, J.C. & van Ommen, G.J. Advances in Duchenne muscular dystrophy gene therapy. Nat. Rev. Genet. 4, 774-783 (2003).
4. Harper, S.Q. et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. (see comments) 8, 253-261 (2002).
5. Manno, O.S. et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101, 2963-2972 (2003).
6. Song, S. et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95, 14384-14388 (1998).
7. Fraites, T.J. Jr. et al. Correction of the enzymatic and functional deficits in a model of pompe disease using adeno-associated virus vectors. Mol. Ther. 5, 571-578 (2002).
8. Xiao, X., Li, J. & Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108 (1996).
9. Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082-14087 (1996).
10. Fisher, K.J. et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312 (1997).
11. Kawada, T. et al. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters. Proc. Natl. Acad. Sci. USA 99, 901-906 (2002).
12. Budker, V., Zhang, G., Danko, I., Williams, P. & Wolff, J. The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther. 5, 272-276 (1998).
13. Greelish, J.P. et al. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med. 5, 439-443 (1999).
14. Hoshijima, M. et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8, 864-871 (2002).
15. Li, J. et al. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors. Gene Ther. 10, 1807-1813 (2003).
16. Rucker, M. et al. Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: pompe disease. Development 131, 3007-3019 (2004).
17. Cordier, L. et al. Rescue of skeletal muscles of gamma-sarcoglycan- deficient mice with adeno-associated virus-mediated gene transfer. Mol. Ther. 1, 119-129 (2000).
18. Dressman, D. et al. Delivery of alpha- and beta-Sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity. Hum. Gene Ther. 13, 1631-1646 (2002).
19. Chao, H. et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2, 619-623 (2000).
20. Hammermann, M. et al. Salt-dependent DNA superhelix diameter studied by small angle neutron scattering measurements and Monte Carlo simulations. Biophys. J. 75, 3057-3063 (1998).
21. Yoshida, K. et al. Fabrication of a new substrate for atomic force microscopic observation of DNA molecules from an ultrasmooth sapphire plate. Biophys. J. 74, 1654-1657 (1998).
22. Pruchnic, R. et al. The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. Hum. Gene Ther. 11, 521-536 (2000).
23. Xiao, W. et al. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994-4003 (1999).
24. Gao, G.P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854-11859 (2002).
25. Gao, G. et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388 (2004).
26. Summerford, C. & Samulski, R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445 (1998).
27. Walters, R.W. et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276, 20610-20616 (2001).
28. Di Pasquale, G. et al. Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9, 1306-1312 (2003).
29. Kaludov, N., Brown, K.E., Walters, R.W., Zabner, J. & Chiorini, J.A. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75, 6884-6893 (2001).
30. Wang, Z. et al. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111 (2003).
31. Xu, L. et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum. Gene Ther. 12, 563-573 (2001).
32. Gregorevic, P. et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10, 828-834 (2004).
33. Li, J. et al. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther. 6, 74-82 (1999).
34. Li, X., Eastman, E.M., Schwartz, R.J. & Draghia-Akli, R. Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol. 17, 241-245 (1999).
35. Hagstrom, J. E. et al. A facile nonviral method for delivering genes and sirnas to skeletal muscle of mammalian limbs. Mol. Ther. 10, 386-398 (2004).
36. Arruda, V.R. et al. Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model. Blood; published online 12 October 2004.
37. Lee, G.G. et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances T(H)2-mediated sensitization and inflammation in the lung. Nat. Med. 10, 1095-1103 (2004).
38. Kern, A. et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 77, 11072-11081 (2003).
39. Hauck, B., Chen, L. & Xiao, W. Generation and characterization of chimeric recombinant AAV vectors. Mol. Ther. 7, 419-425 (2003).
40. Rabinowitz, J.E. et al. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J. Virol. 78, 4421-4432 (2004).
41. Shi, W., Arnold, G.S. & Bartlett, J.S. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum. Gene Ther. 12, 1697-1711 (2001).
42. Loiler, S.A. et al. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther. 10, 1551-1558 (2003).
43. Bartlett, J.S., Kleinschmidt, J., Boucher, R.C. & Samulski, R.J. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab′gamma)2 antibody. Nat. Biotechnol. (erratum in Nat. Biotechnol. 17, 393, 1999) 17, 181-186 (1999).
44. Xiao, X., Li, J. & Samulski, R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232 (1998).
45. Rabinowitz, J.E. et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76, 791-801 (2002).
46. Rutledge, E.A., Halbert, C.L. & Russell, D.W. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72, 309-319 (1998).
47. Li, J., Samulski, R.J. & Xiao, X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236-5243 (1997).
48. Snyder, R., Xiao, X. & Samulski, R.J. Production of recombinant adeno-associated viral vectors, in Current Protocols in Human Genetics (eds. Dracopoli, N. et al.) 12.11.11-12.12.23 (John Wiley & Sons Ltd., New York, 1996).
49. Sands, M.S. & Barker, J.E. Percutaneous intravenous injection in neonatal mice. Lab. Anim. Sci. 49, 328-330 (1999).